Scholarlink

<p>The management of pleural infection remains highly challenging. Rational selection of appropriate local treatment strategies is crucial for successful management. Local treatment decisions are primarily guided by clinical features, pleural fluid biochemical parameters, and imaging characteristics, with pleural fluid pH below 7.2 directly indicating the need for pleural drainage. When multiloculated pleural effusion develops, simple drainage frequently fails, necessitating advanced interventions including intrapleural fibrinolytic therapy (IPFT), medical thoracoscopy (MT), or surgical intervention. Current evidence supports the combination of recombinant tissue plasminogen activator (t-PA) and deoxyribonuclease (DNase) as the most validated fibrinolytic regimen. MT combined with IPFT offers a promising minimally invasive approach for selected patients. Video-assisted thoracoscopic surgery (VATS) remains an important treatment option, though recent evidence from the MIST-3 feasibility trial suggests that early IPFT may achieve better quality of life outcomes. Traditional open decortication remains a backup treatment option for patients with complex pleural infection. This review aims to summarize recent advances in local treatment of pleural infection and provide clinical reference for physicians in local treatment decision-making for pleural infection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Local management of pleural infection: a narrative review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月3日

查看全文
  • Liang Zhou,
  • Menglin Yao,
  • Jiahe Li,
  • Weimin Li,
  • Fengming Luo,
  • Kaige Wang

摘要

The management of pleural infection remains highly challenging. Rational selection of appropriate local treatment strategies is crucial for successful management. Local treatment decisions are primarily guided by clinical features, pleural fluid biochemical parameters, and imaging characteristics, with pleural fluid pH below 7.2 directly indicating the need for pleural drainage. When multiloculated pleural effusion develops, simple drainage frequently fails, necessitating advanced interventions including intrapleural fibrinolytic therapy (IPFT), medical thoracoscopy (MT), or surgical intervention. Current evidence supports the combination of recombinant tissue plasminogen activator (t-PA) and deoxyribonuclease (DNase) as the most validated fibrinolytic regimen. MT combined with IPFT offers a promising minimally invasive approach for selected patients. Video-assisted thoracoscopic surgery (VATS) remains an important treatment option, though recent evidence from the MIST-3 feasibility trial suggests that early IPFT may achieve better quality of life outcomes. Traditional open decortication remains a backup treatment option for patients with complex pleural infection. This review aims to summarize recent advances in local treatment of pleural infection and provide clinical reference for physicians in local treatment decision-making for pleural infection.